AGER and neoplasm: RAGE over-expression in EC adversely correlated with patient survival; RAGE-ADC: 100-fold more effective in EC cells than non-malignant cells; 200-fold more cytotoxic than the drug alone; non-toxic to normal mouse model and substantial tumour growth suppression in mouse xenograft model of EC